Mird-226 [work] Jun 2026

The MIRD-226 project aims to:

One of the key innovations of the MIRD-226 is its integral design, which incorporates all the major components of the reactor, including the reactor vessel, steam generator, and pressurizer, into a single unit. This design approach eliminates the need for large pipes and complex plumbing, reducing the risk of accidents and improving overall safety. Additionally, the MIRD-226 features a passive cooling system, which uses natural circulation to remove heat from the reactor, eliminating the need for electric pumps and reducing the risk of core meltdown. MIRD-226

Radioisotopes, also known as radionuclides, are atoms that contain an unstable nucleus and undergo radioactive decay, emitting ionizing radiation in the process. These isotopes have been widely used in various fields, including medicine, industry, and scientific research. In medicine, radioisotopes are used for diagnostic and therapeutic purposes, such as imaging, cancer treatment, and research. The MIRD-226 project aims to: One of the

Internal radiation dosimetry is a critical aspect of nuclear medicine, as it enables the estimation of the absorbed dose by patients from radiopharmaceuticals administered for diagnostic or therapeutic purposes. The MIRD Committee, established in 1967, has been instrumental in developing and refining guidelines for internal dosimetry. MIRD-226 is the latest in a series of reports and guidelines published by the committee, aiming to provide a comprehensive framework for internal dosimetry. Radioisotopes, also known as radionuclides, are atoms that